Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-02-14
2006-02-14
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C435S007950, C436S501000, C436S510000, C436S518000, C436S811000, C530S300000, C530S350000
Reexamination Certificate
active
06998243
ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.
REFERENCES:
patent: 5538897 (1996-07-01), Yates, III et al.
patent: 5849297 (1998-12-01), Harrison et al.
patent: 6221657 (2001-04-01), Harrison et al.
patent: 6268485 (2001-07-01), Farries et al.
patent: 6617308 (2003-09-01), Jackowski et al.
patent: WO 87/06344 (1987-10-01), None
patent: WO 91/13352 (1991-09-01), None
patent: WO 98/32390 (1998-07-01), None
patent: WO 00/49410 (2000-08-01), None
patent: WO 01/05422 (2001-01-01), None
Lewis et al. Chemical synthesis of hemopoietic growth factors: an approach to protein design. Protein structures, folding, and design, pp. 417-427, copyright 1987 Alan R. Liss, Inc.
Richter et al, Composition of the peptide fraction in human blood plasma: database of circulating human peptides, J. Chrom. B. Biomed. Sci. Appl., 726, 1-2, (1999), pp. 25-35.
Takahashi et al, Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody, Clin. Chem., 45, 8, (1999), pp. 1307-1311.
Tang, et al., “Contribution of Renal Secreted Completed C3 to the Circulating Pool in Humans”, Journal of Immunology (1999), vol. 162, No. 7, pp. 4336-4341.
Koch, et al., “A Novel Polymorphism of Human Complement Component C3 Detected by Means of a Monoclonal Antibody”, Immunogenetics (1986), vol. 23, No. 5, pp. 322-325.
Agarwal, et al., “Immunologic Parameters in Infective Endocarditis: A Prospective Study”, Indian Heart Journal (May 1991), vol. 43, No. 3, pp. 179-183.
Harrison et al., “Structure of C3f, a Small Peptide Specifically Released during Inactivation of the Third Component of Complement”, Component (1988), vol. 5, No. 1, pp. 27-32.
Kristensen, et al., “Association Between Coronary Heart Disease and the C3F-Gene in Essential Hypertension”, Circulation (1978), vol. 58, No. 4, pp. 622-625.
Jackowski George
Marshall John
Thatcher Brad
Vrees Tammy
Yantha Jason
Cook Lisa V.
Le Long V.
McHale & Slavin P.A.
Syn X Pharma, Inc.
LandOfFree
Biopolymer marker indicative of disease state having a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biopolymer marker indicative of disease state having a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biopolymer marker indicative of disease state having a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3641051